Gynaecological cancer in Australia
The following material has been sourced from the Australian Institute of Health and Welfare
Gynaecological cancer incorporates ICD-10 cancer codes C51 (Malignant neoplasm of vulva), C52 (Malignant neoplasm of vagina), C53 (Malignant neoplasm of cervix), C54 (Malignant neoplasm of corpus uteri), C55 (Malignant neoplasm of uterus, part unspecified), C56 (Malignant neoplasm of ovary), C57 (Malignant neoplasm of other and unspecified female genital organs) and C58 (Malignant neoplasm of placenta).
Estimated* number of new cases of gynaecological cancer diagnosed in 2016
Estimated % of all new female cancer cases diagnosed in 2016
Estimated number of deaths from gynaecological cancer in 2016
Estimated % of all female deaths from cancer in 2016
Chance of surviving at least 5 years (2008–2012)
Females living with gynaecological cancer at the end of 2010 (diagnosed in the 5 year period 2006 to 2010)
How common is gynaecological cancer in Australia?
In 2012, the age-standardised incidence rate was 40 cases per 100,000 females.d In 2016, it is estimated that the age-standardised incidence rate will be 40 cases per 100,000 females.
Gynaecological cancer was the 3rd most commonly diagnosed cancer among females in Australia in 2012. It is estimated that it will remain the 3rd most commonly diagnosed cancer among females in 2016.
In 2016, it is estimated that the risk of a female being diagnosed with gynaecological cancer by her 85th birthday will be 1 in 22.
In 2016, it is expected that the incidence rate of gynaecological cancer is expected to generally increase with age (see figure below).
Figure 1: Estimated age-specific incidence rates for gynaecological cancer, 2016
Source: AIHW analysis of the Australian Cancer Database, (see source table 1).
Deaths from gynaecological cancer
In 2013, there were 1,762 deaths from gynaecological cancer in Australia. In 2016, it is estimated that this will decrease to 1,743 deaths.c
In 2013, the age-standardised mortality rate was 13 deaths per 100,000 females.d In 2016, it is estimated that the age-standardised mortality rate will be 11 deaths per 100,000 females.
In 2013, gynaecological cancer accounted for the 4th highest number of deaths from cancer among females in Australia. It is estimated that it will remain the 4th most common cause of death from cancer among females in 2016.
In 2016, it is estimated that the risk of a female dying from gynaecological cancer by their 85th birthday will be 1 in 65.
Trends in gynaecological cancer
The number of new cases of gynaecological cancer diagnosed increased from 2,948 in 1982 to 5,199 in 2012.
Over the same period, the age-standardised incidence rate decreased from 44 cases per 100,000 females in 1982 to 40 cases per 100,000 females in 2012.
The number of deaths from gynaecological cancer increased from 1,120 in 1968 to 1,762 in 2013.
Over the same period, the age-standardised mortality rate decreased from 23 deaths per 100,000 females in 1968 to 13 deaths per 100,000 females in 2013.
Figure 2: Age-standardised incidence rates for gynaecological cancer 1982–2012 and age-standardised mortality rates for gynaecological cancer 1968–2013
Note: Incidence rates available for 1982–2012, and mortality rates available for 1968–2013.
Source: Australian Institute of Health and Welfare, (see source table 2).
Survival from gynaecological cancer
In 2008–2012 in Australia, females diagnosed with gynaecological cancer had a 68% chance of surviving for 5 years compared to their counterparts in the general Australian population.
Between 1983–1987 and 2008–2012, 5-year relative survival from gynaecological cancer improved from 60% to 68%.
Figure 3: 5-year relative survival from gynaecological cancer, 1983–1987 to 2008–2012
Source: AIHW analysis of the Australian Cancer Database, (see source table 3).
Prevalence of gynaecological cancer
The prevalence for 1, 5 and 29 years given below are the number of females living with gynaecological cancer at the end of 2010 who had been diagnosed in the preceding 1, 5 and 29 years respectively.
One year prevalence
At the end of 2010, there were 4,463 females living who had been diagnosed with gynaecological cancer that year.
Five year prevalence
At the end of 2010, there were 17,146 females living who had been diagnosed with gynaecological cancer in the previous 5 years (from 2006 to 2010).
29 year prevalence
At the end of 2010, there were 52,625 females living who had been diagnosed with gynaecological cancer in the previous 29 years (from 1982 to 2010).
|Age group (years)||Number of new cases
per 100,000 females
|Year||Rate of new diagnoses per 100,000 females||Rate of deaths per 100,000 females|
|Year||5-year relative survival (%)|
International Statistical Classification of Diseases and Related Health Problems Version 10 (ICD-10)
Cancer, like other health conditions, is classified by the International Statistical Classification of Diseases and Related Health Problems Version 10 (ICD-10). This is a statistical classification, published by the World Health Organization, in which each morbid condition is assigned a unique code according to established criteria.
Future estimates for incidence and mortality are a mathematical extrapolation of past trends. They assume that the most recent trends will continue into the future, and are intended to illustrate future changes that might reasonably be expected to occur if the stated assumptions continue to apply over the estimated period. Actual future cancer incidence and mortality rates may vary from these estimations for a variety of factors. New screening programs may increase the detection of new cancer cases; new vaccination programs may decrease the risk of developing cancer; and improvements in treatment options may decrease mortality rates.
Due to the rounding of these estimates, male and female incidence and mortality may not sum to person incidence and mortality.
Cancer incidence indicates the number of new cancers diagnosed during a specified time period (usually one year).
- The 2012 national incidence counts include estimates for NSW and the ACT because the actual data were not available.
- The 2016 estimates are based on 2002–11 incidence data. Due to rounding of these estimates, male and female incidence may not sum to person incidence.
Cancer mortality refers to the number of deaths occurring during a specified time period (usually one year) for which the underlying cause of death is cancer.
- The 2016 estimates are based on 2002–13 mortality data.
Prevalence of cancer refers to the number of people alive with a prior diagnosis of cancer at a given time. It is distinct from incidence (see above). The longest period for which it is possible to calculate prevalence using the available national data (from 1982 to 2010) is currently 29 years. This span is used to estimate the 'total' prevalence of cancer at the end of 2010, noting that people diagnosed with cancer before 1982 are not included.
Age standardised rates
- Incidence and mortality rates expressed per 100,000 population are age-standardised to the Australian population as at 30 June 2001.